AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial

Richard B. Lipton, James S. McGinley, Kenneth J. Shulman, Stephen D. Silberstein, R. J. Wirth, Dawn C. Buse

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint Dive into the research topics of 'AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences